Hta Consulting

What Hta Consulting does

HTA Consulting is a Kraków, Poland-based decision sciences company founded in 2001 that specializes in health technology assessment (HTA) for drugs, medical devices, and diagnostic methods. The firm serves pharmaceutical manufacturers, healthcare policymakers, healthcare organizations, and medical technology companies, producing comprehensive HTA reports, reimbursement strategies, market access analyses, cost-effectiveness and budget impact analyses, and negotiation workshops. Its core technology stack combines data engineering, data science, and decision science methodologies, supported by three proprietary platforms: IKARpro (an Interactive Compendium of Reimbursement Analyses for Poland), IDA Reports (interactive Power BI–based reimbursement and market access analytics), and the GAP V4 platform (cross-country access benchmarking across Poland, Hungary, Czechia, and Slovakia).

The company's business model is predominantly project-based professional services, with typical HTA report timelines of 3 to 6 months and quote-based, engagement-specific pricing. Headcount is reported as 50+ on the company website and 51–200 on LinkedIn. Revenue is supplemented by self-serve data platform access (IKARpro, GAP V4), tailor-made training courses, and scientific publications, providing a partial shift from pure consulting toward recurring data revenue. HTA Consulting operates from a single Kraków headquarters and serves clients in Central Europe, broader Europe, Asia, and Australia, with leadership continuity under co-founder President Robert Plisko (since 2006) and Vice-President Magdalena Władysiuk. The firm maintains two legal entities (HTA Consulting Poland sp. z o.o. and HTA Consulting sp. z o.o.) and shows no evidence of external institutional or private equity ownership.

Name

Hta Consulting

Legal name

HTA Consulting Poland sp. z o.o.

Website

https://hta.pl

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

101–250 employees

Short description

HTA Consulting is a Kraków-based decision sciences company founded in 2001 that provides health technology assessment, reimbursement strategy, and market access services to pharmaceutical companies, medical technology firms, and healthcare policymakers in Central Europe and selected international markets.

Ownership category

akta.pro rank

Product category

Health Technology Assessment (HTA) and Healthcare Market Access Consulting

NAICS

Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Payer & HTA Engagement (Reimbursement/Submissions) (HLAIAKAD)

akta.pro secondary industries

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN), Economic Evaluation & Health Technology Assessment (Public Programs) (HLAJANAL)

Keywords

• Health technology assessment
• Market access consulting
• Reimbursement strategy
• Pharma HTA reports
• Healthcare decision science

Headquarters

HQ city

Kraków

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. HTA Consulting Services: Professional consulting services including HTA report preparation, reimbursement strategies, and market access analyses for pharmaceutical companies and healthcare organizations. Services are project-based with deliverables tailored to client needs. Timeline typically ranges from 3 to 6 months per full HTA report.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

HTA Consulting prepares comprehensive Health Technology Assessment (HTA) reports covering Decision Problem Analysis, Clinical Analysis, Economic Analysis, and Budget Impact Analysis, and delivers reimbursement strategy, market access analysis, and negotiation support to pharmaceutical manufacturers, medical technology companies, healthcare providers, and policymakers. The firm also operates proprietary data and analytics platforms (IKARpro, IDA Reports, and the GAP V4 platform) and offers tailor-made training in HTA and decision science.

Product overview

HTA Consulting operates as a Decision Sciences Company offering a unified portfolio of interconnected products and services for healthcare decision-making. The core offerings include: IKARpro (Interactive Compendium of Reimbursement Analyses) for accessing comprehensive reimbursement and sales data in Poland; IDA Reports providing TOP10 and GAP analysis reports via Power BI; and the GAP Project platform for measuring access to novel medicines in V4 countries. Additionally, the company delivers HTA Full Reports encompassing clinical analysis, economic analysis, and budget impact analysis. Strategic consulting services (reimbursement strategy, negotiation workshops, advisory boards) and tailor-made training courses complement the product suite. The company also develops system reports for clients and maintains scientific publications.

Differentiator

Problem solved

Functional benefit

Brands

• IkarPro: Interactive Compendium of Reimbursement Analyses providing access to comprehensive reimbursement and sales data in Poland. Offers modules and reports facilitating analysis of price changes and reimbursement limits for medicinal products.
• IDA Reports
• GAP Project (GAP V4)

Products and services

• Pre-HTA / HTA Full Report End-to-end HTA report preparation service for pharmaceutical companies, medical technology firms, and healthcare organizations. It defines the clinical context, conducts systematic clinical and economic evaluation, and estimates budget impact to support reimbursement submissions and market access strategies.
• IKARpro Self-serve data and analytics platform offering comprehensive reimbursement and sales data for medicinal products in Poland, with modules and reports for analyzing price changes and reimbursement limits. Targeted at pharmaceutical manufacturers, payers, and analysts needing Polish reimbursement market intelligence.
• IDA Reports Interactive Power BI-based analytics reports (TOP10 and GAP analyses) delivering reimbursement and market access data visualizations, used by HTA Consulting and its clients to monitor and benchmark the reimbursement landscape.
• GAP Project (GAP V4) Online platform and methodology for measuring access to novel medicines across V4 countries, providing multidimensional analysis to support policy-making and cross-country market access benchmarking across oncology, chronic diseases, and orphan diseases.
• Strategic Market Access & Reimbursement Consulting Project-based strategic consulting covering reimbursement strategy, market access planning, negotiation workshops, advisory board support, and tailor-made training courses on HTA, data engineering, and decision science for pharmaceutical and healthcare clients.

Quantifiable outcome

• 24 projects completed, 500+ reports created, 50 reimbursements achieved
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• EESTAHC (European Expert Group on Health Economics)coreStrategic or Co-development PartnerEESTAHC is a European expert group on health economics. HTA Consulting partners with EESTAHC for expertise exchange and collaborative initiatives in health technology assessment across Europe.
• KPRW (Krakowskie Przedsiębiorstwo Rachunkowości i Finansów)minorOthersLocal accounting and finance partner providing financial services support to HTA Consulting operations.
• IAS (Institute for Advanced Studies)coreStrategic or Co-development PartnerInstitute for Advanced Studies partnership for research collaboration and knowledge exchange in health economics and technology assessment.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Others

• RWS Group: RWS Group provides language services, regulatory writing, and HTA-related support to pharmaceutical clients. It is thematically adjacent — operating in the same pharma HTA value chain — but primarily serves as a supplier of translation and regulatory content rather than a direct HTA consultant.

Emerging players

• Cytel: Cytel provides statistical programming, biostatistics, and health economics services to pharma and medical device clients. While its core focus is biostatistics, its HTA-adjacent health economics work and CEE presence make it a meaningful emerging competitor.
• AARDEX Group: AARDEX Group is a Belgium-based health data analytics firm specialising in medication adherence and patient behaviour data. It is an emerging adjacent peer — using similar data engineering and analytics methodologies to HTA Consulting's IKARpro/IDA platforms but focused on adherence rather than reimbursement.

Broad incumbents

• IQVIA: IQVIA is a global clinical research, data, and consulting giant with a dedicated market access and HTA practice. It is a broad incumbent that overlaps with HTA Consulting on payer/HTA engagements but operates across a vastly larger portfolio spanning clinical, commercial, and real-world evidence services.
• Parexel International: Parexel is a global CRO with a market access and HTA consulting practice. As a broad incumbent it overlaps with HTA Consulting on payer evidence generation but serves it as part of a much larger clinical development and regulatory portfolio.

Direct peers

• Evidera: Evidera (owned by PPD/Thermo Fisher Scientific) is a global leader in health economics, outcomes research, HTA, and market access consulting. It is the most directly comparable peer, offering the same core HTA report preparation, economic modelling, and payer engagement services that HTA Consulting delivers in CEE — but at global scale.
• Mtech Access: Mtech Access is a UK-based HTA, market access, and evidence synthesis consultancy serving pharma and medtech clients across Europe. It competes head-to-head with HTA Consulting for pharma HTA engagements, particularly for cross-country European submissions.
• CBPartners: CBPartners is a specialised global pricing, market access, and HTA consultancy serving pharmaceutical and medical device clients. It is a direct competitor in the same niche — HTA reports, reimbursement strategy, and value communication — making it a closely comparable peer despite its broader geographic footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/hta-consulting

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hta Consulting